The frequency of bone marrow stromal cells secreting CXCL12 (CXCL12+) in the BM and CXCR4 expression is increased in AML, potentially due to hypoxic conditions within the microenvironment [78,79]. The gene discussed is CXCR4; the disease is acute myeloid leukemia.